Table 2.
Proportion diagnosed in primary care and proportion of surgically treated patients with ulnar nerve entrapment (UNE) at any level and registered in the Skåne Health Care Register (SHR) and the Swedish National Diabetes Register (NDR) during 2004–2019.
| Level of care (primary care) | Surgically treated | |
|---|---|---|
| All patients | 449 (7.0) | 2389 (37.0) |
| Men | 229 (7.2) | 1228 (38.5) |
| Women | 220 (6.7) | 1161 (35.6) |
| No diabetes | 425 (7.4) | 2131 (36.8) |
| Diabetes | 24 (3.6) | 258 (38.7) |
| Type 1 | 2 (1.6) | 43 (35.0) |
| Type 2 | 22 (4.0) | 215 (39.5) |
| Glycemic control | ||
| Optimal | 13 (5.6) | 88 (38.4) |
| Acceptable | 8 (3.6) | 82 (36.6) |
| Poor | 3 (1.4) | 88 (41.1) |
| Retinopathy | 8 (2.7) | 131 (39.0) |
| No retinopathy | 15 (4.5) | 118 (39.7) |
| Level of care | ||
| Primary care | 59 (13.1) | |
| Specialist care | 2330 (38.8) | |
Values presented as n (%). Level of care refers to where the patients had their first UNE diagnosis. Surgically treated patients include patients with at least one registered surgical procedure for UNE at any level during the study period. Glycemic control is defined as optimal (HbA1c ≤ 51.1 mmol/mol), acceptable (HbA1c 51.2–63.7 mmol/mol), and poor (HbA1c > 63.7 mmol/mol).